CTRI/2023/07/054906尚未招募Unknown
Single dose Rituximab in steroid dependent nephrotic syndrome and frequently relapsing nephrotic syndrome in children 2-18 years of age in a tertiary care hospital during a period of 1 year - A pre post study - NI
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Children with Steroid dependent nephrotic syndrome and frequently relapsing nephrotic syndrome
排除标准
- •Children with Steroid resistant nephrotic syndrome
- •Children with Chronic kidney disease
- •Children who have already received Rituximab within last 1 year
- •Children who are on Cyclosporin and on other calcineurin inhibitors
研究者
相似试验
进行中（未招募）
不适用
Rituximab treatment in patients with tjyroid associated that do not respond to intravenous steroids or relapse after intravenous steroid treatmentThyroid associated opthalmopathyEUCTR2011-000899-33-SEDepartment of Endocrinology, Sahlgrenska University Hospital50
招募中
不适用
Study on the effect of rituximab for steroid-dependent nephrotic syndromesteroid-dependent nephrotic syndromeJPRN-UMIN000017470Graduate School Medical Sciences, Kyushu University5
进行中（未招募）
不适用
Efficacy of Rituximab treatment in patients with rheumatoid arthritis having inadequate response to TNF blockerTo investigate the efficacy of treatment with Rituximab (MabThera®) in patients with active RA whose current treatment with one or more TNF-blocker (Etanercept - Enbrel®, Infliximab – Remicade® or Adalimumab - Humira®) alone or in combination with MTX is insufficient measured by DAS28 activity index.EUCTR2006-004673-98-HURoche (Hungary) Ltd.20
已完成
3 期
ncontrol trial of rituximab treatment on steroid dependent and frequently relapsing minimal cahnge nephrotic syndrome(MCNS)steroid dependent and frequently relapsing minimal change nephrotic syndromeJPRN-UMIN000005231Department of Medicine, Kidney Center, Tokyo Women's Medical University50
已完成
不适用
Phase II study of Rituximab in Patients with Systemic Lupus ErythematosusSystemic lupus erythematosusJPRN-UMIN000000762Zenyaku Kogyo Co., Ltd.70